CEO Dr Peter Sondermann © Tacalyx GmbH
Financing

Tacalyx’ extends seed capital financing

Glycan target specialist Tacalyx GmbH expands its seed financing to €14m to advance its anti-TACA cancer therapies.

Read more
PAS amd CD3 staining of renal tissue at day 10 (scale bars, 10 μm). © Leon U. B. Enk
T Cells

CRISPR screen highlights genes behind T cell plasticity in autoimmunity

Researchers at University Hospital Hamburg-Eppendorf have laid the foundation to screen for molecules that shift Th17 cells from proinflammatory or immune-dampening mode.
 

Read more
© Elsie Biotechnology
acquisition

GSK closes US$50m acquisition with Elsie Biotechnologies Inc

GSK takes over Elsie Biotechnologies in US$50m deal to boost its oligonucleotide-based drug platform and pipeline.

Read more
Lu 177-dotatate (pink and orange) binds to somatostatin receptors (green) on neuroendocrine tumor cells (blue) and kills the cells through the release of radioactive particles.@ NCI. Credit: Adapted from Frontiers in Oncology. January 2019. Front. Oncol. doi: 10.3389/fonc.201800663
radiopharmaceutical

ITM gets equity to launch Phase III lead radiopharmaceutical ITM-11

ITM Isotope Technologies Munich SE has raised €188m ito boost radiopharma pipeline, contract manufacturing cpacity, and launch ITM-11.

Read more
Quantro used thiol(SH)-linked alkylation for the metabolic sequencing of RNA (SLAM seq), an orthogonal-chemistry-based RNA sequencing technology that detects 4-thiouridine (s4U) incorporation in RNA species at single-nucleotide resolution, to measure RNA-polymerase-II-dependent gene expression dynamics. © QUANTRO Therapeutics GmbH
Collaboration

Quantro Therapeutics cashes in milestone payment from Boehringer Ingelheim

Viennese biotech QUANTRO Therapeutics identifies small molecule targeting an onkogenic transcription factor in Boehringer Ingelheim collab.

Read more
DefiniGEN's hepatocyte NAFLD cell_model. © DefiniGEN' Ltd
cell culture

DefiniGEN and Atelerix prevent freezing damage in cell models

DefiniGEN Ltd., and Atelerix Ltd. have successfully shipped in vitro liver models from the UK to the US without freezing them thus preventing cell damage and loss-of function.

Read more
Approvals for RNA-based drugs in the past decade. © IQVIA
CDMO

Wacker Chemie AG opens €100m RNA manufacturing site

With the opening of a production centRE for RNA vaccines and therapeutics, German CDMO Wacker Biotech is expanding its expertise in the field of RNA active ingredients.

Read more
Evotec headquarters in Hamburg. © Evotec SE
CRO

Consortium led by Evotec enters obesity drug space

Drug discovery CRO Evotec SE announced has entered into a partnership with Inserm, Lille University Hospital and Inserm Transfert to screen new biomarkers and targets in obesity and metabolic diseases.

Read more
Award winner Jeroen Verheyen (CEO and co-founder, Semarion, left) with Ignite Award judge Severine Tamas-Lhoustau, Managing Director of Novoptim (Paris, France, right). © Jill Hronek, Director Marketing and Communication at SLAS
Lab automation

Semarion Ltd. wins Ignite SME award at SLAS Europe

,

UK-based Semarion Ltd. was honoured as the most innovative company in the field of laboratory automation at SLAS Europe 2024 in Barcelona.

Read more
Fundus in diabetis retinopathy. © By Shaofeng Hao, Changyan Liu, Na Li, Yanrong Wu, Dongdong Li, Qingyue Gao, Ziyou Yuan, Guanyan Li, Huilin Li, Jianzhou Yang, and Shengfu Fan. - (2022). - wikipedia.org/PLoS One (doi:10.1371/journal.pone.0275983.
acquisition

MSD grabs Eyebiotech Ltd for US$1.3bn upfront

US pharma giant Merck Sharp & Dohme (MSD) is decided to acquire London-based ophtalmology expert Eyebiotech Ltd for upt to US$3bn., US$1.7bn in future milestones.

Read more